Recruiting

A Study of LY3462817 in Participants With Rheumatoid Arthritis

J1A-MC-KDAD - ClinicalTrials.gov - NCT04634253

The reason for this study is to see if the study drug LY3462817 is safe and effective in participants with moderately to severely active rheumatoid arthritis (RA).
How long will I be in the trial?
The study will last about 36 weeks and may include up to 12 visits.
Email
Recruiting

A Study of LY3462817 in Participants With Rheumatoid Arthritis

J1A-MC-KDAD - ClinicalTrials.gov - NCT04634253

The reason for this study is to see if the study drug LY3462817 is safe and effective in participants with moderately to severely active rheumatoid arthritis (RA).
How long will I be in the trial?
The study will last about 36 weeks and may include up to 12 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have a diagnosis of adult onset rheumatoid arthritis for at least 3 months

Participants must NOT

Participants must not have had cancer within the last 5 years, except for some types of skin cancer or cervical cancer

Participants must not have cervical dysplasia

Participants must not have had certain types of infections within the last 3 months

Participants must not have HIV

Participants must not have current hepatitis virus B or C infection

Trial Summary

Conditions the trial is for

Rheumatoid Arthritis

What the trial is testing?

LY3462817

Could I receive a Placebo?

yes

Enrollment Goal

80

Trial Dates

January 2021 - August 2022

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have a diagnosis of adult onset rheumatoid arthritis for at least 3 months

Participants must NOT

Participants must not have had cancer within the last 5 years, except for some types of skin cancer or cervical cancer

Participants must not have cervical dysplasia

Participants must not have had certain types of infections within the last 3 months

Participants must not have HIV

Participants must not have current hepatitis virus B or C infection

Trial Summary

Conditions the trial is for

Rheumatoid Arthritis

What the trial is testing?

LY3462817

Could I receive a Placebo?

yes

Enrollment Goal

80

Trial Dates

January 2021 - August 2022

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Rheumatoid Arthritis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?